What Key Clinical Differences Between Hypertrophic Scars And Keloids Should Aesthetic Practitioners Assess Prior To Selecting Laser Resurfacing Or Scar Revision Equipment? Master The Distinction For Safe Treatment

The most important distinction is whether the scar stays within the original wound or grows beyond it. Hypertrophic scars usually develop within 4–8 weeks after wound closure, remain confined to the injury, and may flatten gradually. Keloids can arise months or years after minor trauma, extend into uninjured skin, rarely regress spontaneously, and carry a substantially higher risk of recurrence or worsening after procedures that create additional tissue injury.

A raised scar that remains within the wound boundary may be hypertrophic; a scar that crosses into previously normal skin should be treated as potentially keloidal until properly assessed. This classification affects procedural risk, treatment parameters, the need for adjunctive therapy, and whether laser resurfacing is appropriate at all.

Establish Whether the Scar Is Hypertrophic or Keloidal

Compare the Scar With the Original Injury

Hypertrophic scars remain within the dimensions and outline of the original wound, incision, burn, or trauma. Their elevation may be substantial, but the scar does not progressively invade adjacent normal skin.

Keloids extend beyond the original wound margins. The extension may be lateral, outward, or irregular, producing a lesion that is larger than the initiating injury.

This boundary assessment is often the most useful clinical discriminator before selecting fractional CO2, Er:YAG, Nd:YAG, vascular laser, or radiofrequency equipment.

Assess the Timing of Onset

Hypertrophic scars commonly become evident within approximately 4–8 weeks after wound closure or trauma. They often emerge during the active remodeling phase of healing.

Keloids may appear much later, including months or several years after the triggering injury. They may also follow minor trauma, piercing, acne, burns, or surgical procedures that initially seemed to heal normally.

A delayed or apparently disproportionate scar should increase suspicion of keloid biology, particularly when combined with extension beyond the wound.

Evaluate the Clinical Course

Hypertrophic scars may stabilize and gradually flatten over time. Their activity can diminish as the remodeling process progresses.

Keloids tend to remain persistent or continue enlarging. They rarely resolve without treatment and may recur after excision or other interventions.

The trajectory matters because a stable, regressing scar presents a different procedural risk from an actively expanding lesion.

Examine the Lesion’s Morphology and Symptoms

Characterize Color, Surface, and Consistency

Hypertrophic scars are commonly pink to red, firm, and raised. They may appear linear, papular, or nodular, especially along high-tension wounds.

Keloids are often firm, shiny, and bosselated, with irregular contours. They may be pink, red, or darker than surrounding skin and can show visible telangiectasia.

These findings support the diagnosis but should not replace assessment of the lesion’s borders and behavior.

Ask About Pain, Tenderness, and Itching

Keloids may be tender, painful, or intensely pruritic. Symptoms can persist as the lesion enlarges.

Hypertrophic scars can also itch or feel tight, particularly during early maturation, but symptoms often lessen as the scar becomes inactive.

A symptomatic, enlarging lesion that extends beyond the wound should be approached as high risk for keloid recurrence or stimulation.

Consider Location and Skin Phototype

Hypertrophic scarring is common in areas exposed to wound tension. Keloids may occur after relatively minor injury and are more frequent in people with darker skin phototypes.

Location and phototype do not establish the diagnosis alone. They do, however, influence counseling about recurrence, post-inflammatory pigment alteration, and the consequences of excessive thermal or mechanical injury.

Translate the Diagnosis Into Equipment Selection

When the Pattern Is Consistent With a Hypertrophic Scar

A confined, relatively early hypertrophic scar may be considered for carefully selected vascular, fractional, or other scar-remodeling approaches, depending on its color, thickness, maturity, and symptoms.

Vascular features may influence consideration of vascular-targeted devices, while texture and thickness may influence fractional or remodeling technologies. The choice should follow the dominant clinical problem rather than the device available in the clinic.

When Keloid Is Suspected

A keloid should not be treated as an ordinary textural scar. Ablative resurfacing, microneedling radiofrequency, or other procedures that add controlled injury can potentially aggravate fibroproliferative activity in susceptible patients.

The practitioner should consider specialist assessment and a multimodal plan. Options may include silicone or pressure therapy and medical treatments such as intralesional therapy, with laser used only when its role and risk have been carefully evaluated.

Match Parameters to Tissue Risk

The diagnosis should inform wavelength, pulse duration, fluence, density, treatment depth, and interval between sessions. More aggressive settings are not automatically more effective when the tissue has a keloidal tendency.

The plan should also account for wound-healing history, prior recurrence, current scar activity, and the patient’s risk of post-inflammatory hyperpigmentation.

Determine Whether the Lesion Is Active or Mature

Identify Signs of Ongoing Activity

Recent color change, enlargement, tenderness, pruritus, and continued thickening suggest active scar behavior. An active lesion deserves more caution than a stable, pale, softening scar.

Documenting dimensions and photographing the lesion can help determine whether it is changing before treatment begins.

Separate Texture From Active Proliferation

A mature scar may remain raised or irregular even after its biological activity has decreased. Conversely, a relatively small lesion may still be actively expanding.

Equipment selection should therefore be based on both visible morphology and clinical history, not on height or color alone.

Review Previous Procedures

Ask whether the scar worsened after surgery, injection, piercing, laser treatment, microneedling, or other trauma. A history of recurrence after intervention is an important warning sign.

Previous treatment failure does not by itself prove that a lesion is a keloid, but it should prompt reassessment of the diagnosis and treatment strategy.

Understanding the Trade-offs

Laser Resurfacing Can Add Injury

Fractional CO2 and Er:YAG systems can remodel scar texture, but they create thermal or ablative injury. Microneedling radiofrequency likewise introduces controlled tissue damage.

That injury may be reasonable for selected hypertrophic scars, but it can be poorly suited to an actively expanding or strongly recurrent keloid.

A Less Aggressive Treatment Is Not Always a Safer Treatment

Reducing energy or density may reduce injury, but it does not eliminate the possibility of recurrence or progression in a keloid-prone patient. Treatment should not proceed solely because parameters can be lowered.

The central safety decision is whether the expected benefit justifies creating additional injury in that individual.

Diagnosis May Remain Uncertain

Some scars have overlapping features, particularly early lesions or scars altered by previous treatment. When the boundary, history, or behavior is unclear, an experienced dermatology or scar specialist should help establish the diagnosis before elective energy-based treatment.

Combination Therapy Requires Deliberate Planning

Silicone sheeting, pressure therapy, intralesional medication, surgery, and laser may have roles in selected cases. Combining modalities should be based on recurrence risk and treatment goals rather than used automatically.

Patients should understand that keloid treatment often aims to control symptoms and reduce bulk, not guarantee permanent eradication.

Making the Right Choice for Your Goal

The following principles help connect clinical assessment to equipment selection:

If your primary focus is distinguishing the scar type: First compare the lesion with the original wound, then confirm the onset, growth pattern, symptoms, and morphology.
If your primary focus is minimizing recurrence: Treat extension beyond the wound, continued enlargement, prior recurrence, and marked symptoms as warning signs requiring specialist input and cautious planning.
If your primary focus is improving a likely hypertrophic scar: Select the modality according to vascularity, thickness, texture, maturity, skin phototype, and tolerance for downtime rather than choosing equipment by brand or availability.
If your primary focus is treating a suspected keloid: Avoid assuming that resurfacing alone is appropriate; evaluate multimodal therapy and the risk that additional injury could stimulate expansion.
If your primary focus is protecting pigment and wound healing: Use conservative, individualized parameters and include phototype, prior pigmentary response, and healing history in the treatment assessment.

Correct scar classification gives practitioners the clearest basis for choosing effective equipment while controlling the risk of recurrence, progression, and pigmentary complications.

Summary Table:

Feature	Hypertrophic Scar	Keloid
Boundary	Confined to original wound	Extends beyond original wound
Onset	4-8 weeks after injury	Months to years later
Course	May regress over time	Persistent or progressive
Symptoms	Itching, tightness	Pain, tenderness, severe itching
Recurrence	Lower after treatment	High risk, especially with injury
Response to Laser	Generally favorable	Risk of worsening; use caution

Equip your clinic with the right technology for precise scar treatment. At BELIS, we offer advanced laser and aesthetic devices designed to address hypertrophic scars and keloids with safety and efficacy. Our portfolio includes fractional CO2, Er:YAG, Nd:YAG, and more, exclusively for clinics and premium salons. Contact us today to explore solutions that enhance your practice and patient outcomes. Get in touch with our experts.